7.
Ding Y, Jiang Z, Xia B, Zhang L, Zhang C, Leng J
. Mitochondria-targeted antioxidant therapy for an animal model of PCOS-IR. Int J Mol Med. 2018; 43(1):316-324.
PMC: 6257859.
DOI: 10.3892/ijmm.2018.3977.
View
8.
Guastella E, Longo R, Carmina E
. Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes. Fertil Steril. 2010; 94(6):2197-201.
DOI: 10.1016/j.fertnstert.2010.02.014.
View
9.
Guo J, Ye F, Xie W, Zhang X, Zeng R, Sheng W
. The HOXC-AS2/miR-876-5p/HKDC1 axis regulates endometrial cancer progression in a high glucose-related tumor microenvironment. Cancer Sci. 2022; 113(7):2297-2310.
PMC: 9277262.
DOI: 10.1111/cas.15384.
View
10.
Han Y, Zhang W, Liu J, Song Y, Liu T, Li Z
. Metabolomic and Lipidomic Profiling of Preoperative CSF in Elderly Hip Fracture Patients With Postoperative Delirium. Front Aging Neurosci. 2020; 12:570210.
PMC: 7642614.
DOI: 10.3389/fnagi.2020.570210.
View
11.
Hayes M, Urbanek M, Hivert M, Armstrong L, Morrison J, Guo C
. Identification of HKDC1 and BACE2 as genes influencing glycemic traits during pregnancy through genome-wide association studies. Diabetes. 2013; 62(9):3282-91.
PMC: 3749326.
DOI: 10.2337/db12-1692.
View
12.
Huang J, Duan C, Jin S, Sheng C, Wang Y, Yue Z
. HB-EGF induces mitochondrial dysfunction via estrogen hypersecretion in granulosa cells dependent on cAMP-PKA-JNK/ERK-Ca-FOXO1 pathway. Int J Biol Sci. 2022; 18(5):2047-2059.
PMC: 8935223.
DOI: 10.7150/ijbs.69343.
View
13.
Huang X, Hong L, Wu Y, Chen M, Kong P, Ruan J
. Raman Spectrum of Follicular Fluid: A Potential Biomarker for Oocyte Developmental Competence in Polycystic Ovary Syndrome. Front Cell Dev Biol. 2021; 9:777224.
PMC: 8632455.
DOI: 10.3389/fcell.2021.777224.
View
14.
Khan M, Terry A, Priyadarshini M, Ilievski V, Farooq Z, Guzman G
. The hexokinase "HKDC1" interaction with the mitochondria is essential for liver cancer progression. Cell Death Dis. 2022; 13(7):660.
PMC: 9334634.
DOI: 10.1038/s41419-022-04999-z.
View
15.
Ludvik A, Pusec C, Priyadarshini M, Angueira A, Guo C, Lo A
. HKDC1 Is a Novel Hexokinase Involved in Whole-Body Glucose Use. Endocrinology. 2016; 157(9):3452-61.
PMC: 5007896.
DOI: 10.1210/en.2016-1288.
View
16.
Massey V, Parrish A, Argemi J, Moreno M, Mello A, Garcia-Rocha M
. Integrated Multiomics Reveals Glucose Use Reprogramming and Identifies a Novel Hexokinase in Alcoholic Hepatitis. Gastroenterology. 2020; 160(5):1725-1740.e2.
PMC: 8613537.
DOI: 10.1053/j.gastro.2020.12.008.
View
17.
Pang X, Zhao Y, Wang J, Li W, Xiang Q, Zhang Z
. Competing Endogenous RNA and Coexpression Network Analysis for Identification of Potential Biomarkers and Therapeutics in association with Metastasis Risk and Progression of Prostate Cancer. Oxid Med Cell Longev. 2019; 2019:8265958.
PMC: 6701351.
DOI: 10.1155/2019/8265958.
View
18.
Peng Y, Guo L, Gu A, Shi B, Ren Y, Cong J
. Electroacupuncture alleviates polycystic ovary syndrome-like symptoms through improving insulin resistance, mitochondrial dysfunction, and endoplasmic reticulum stress via enhancing autophagy in rats. Mol Med. 2020; 26(1):73.
PMC: 7374902.
DOI: 10.1186/s10020-020-00198-8.
View
19.
Peng Y, Yang X, Luo X, Liu C, Cao X, Wang H
. Novel mechanisms underlying anti-polycystic ovary like syndrome effects of electroacupuncture in rats: suppressing SREBP1 to mitigate insulin resistance, mitochondrial dysfunction and oxidative stress. Biol Res. 2020; 53(1):50.
PMC: 7590702.
DOI: 10.1186/s40659-020-00317-z.
View
20.
Pusec C, De Jesus A, Khan M, Terry A, Ludvik A, Xu K
. Hepatic HKDC1 Expression Contributes to Liver Metabolism. Endocrinology. 2018; 160(2):313-330.
PMC: 6334269.
DOI: 10.1210/en.2018-00887.
View
21.
Qi X, Yun C, Sun L, Xia J, Wu Q, Wang Y
. Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome. Nat Med. 2019; 25(8):1225-1233.
PMC: 7376369.
DOI: 10.1038/s41591-019-0509-0.
View